Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene
about
P1343
Ring finger protein ZIN interacts with human immunodeficiency virus type 1 VifThe double-stranded RNA-binding protein Staufen is incorporated in human immunodeficiency virus type 1: evidence for a role in genomic RNA encapsidationDephosphorylation of CDK9 by protein phosphatase 2A and protein phosphatase-1 in Tat-activated HIV-1 transcription.Selection of high-level resistance to human immunodeficiency virus type 1 protease inhibitorsMethylation of Tat by PRMT6 regulates human immunodeficiency virus type 1 gene expressionEASY-HIT: HIV full-replication technology for broad discovery of multiple classes of HIV inhibitorsPathogenesis of human immunodeficiency virus infectionEfficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signalEstablishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeletonVpx is critical for reverse transcription of the human immunodeficiency virus type 2 genome in macrophagesInhibition of tRNA₃(Lys)-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replicationThe human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor kappaB-dependent expression of antiapoptotic factorsIn vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIVThe association of Nef with a cellular serine/threonine kinase and its enhancement of infectivity are viral isolate dependentEarly steps of retrovirus replicative cycleInhibition of human immunodeficiency virus type-1 (HIV-1) glycoprotein-mediated cell-cell fusion by immunor (IM28)Inactivation of HIV-1 in breast milk by treatment with the alkyl sulfate microbicide sodium dodecyl sulfate (SDS)HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vectorSplicing of human immunodeficiency virus RNA is position-dependent suggesting sequential removal of introns from the 5' endModulating HIV-1 replication by RNA interference directed against human transcription elongation factor SPT5CXCR4 and CCR5 shRNA transgenic CD34+ cell derived macrophages are functionally normal and resist HIV-1 infectionContribution of the C-terminal tri-lysine regions of human immunodeficiency virus type 1 integrase for efficient reverse transcription and viral DNA nuclear importThe cell cycle independence of HIV infections is not determined by known karyophilic viral elements.Targeted infection of HIV-1 Env expressing cells by HIV(CD4/CXCR4) vectors reveals a potential new rationale for HIV-1 mediated down-modulation of CD4Imaging single retrovirus entry through alternative receptor isoforms and intermediates of virus-endosome fusionAntigenic properties of the human immunodeficiency virus envelope glycoprotein gp120 on virions bound to target cellsP2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor InteractionsSynchronized retrovirus fusion in cells expressing alternative receptor isoforms releases the viral core into distinct sub-cellular compartmentsTransgenic cell lines for detection of animal virusesDesign of an engineered N-terminal HIV-1 gp41 trimer with enhanced stability and potencyThe Preserved HTH-Docking Cleft of HIV-1 Integrase Is Functionally CriticalPhosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNAA small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activityAnti-human immunodeficiency virus activity of YK-FH312 (a betulinic acid derivative), a novel compound blocking viral maturation4'-Ethynyl nucleoside analogs: potent inhibitors of multidrug-resistant human immunodeficiency virus variants in vitroInhibitory effects of small-molecule CCR5 antagonists on human immunodeficiency virus type 1 envelope-mediated membrane fusion and viral replicationMichellamine B, a novel plant alkaloid, inhibits human immunodeficiency virus-induced cell killing by at least two distinct mechanismsAmphotericin B derivative blocks human immunodeficiency virus type 1 entry after CD4 binding: effect on virus-cell fusion but not on cell-cell fusionT134, a small-molecule CXCR4 inhibitor, has no cross-drug resistance with AMD3100, a CXCR4 antagonist with a different structure.A broad-spectrum microbicide with virucidal activity against sexually transmitted viruses
P2860
Q24304030-06CF8DC2-70A4-4A17-8B98-4E0983234FB5Q24525207-1DDE7E77-21AA-4525-B5B2-B9174F748FE2Q24535568-097CB41D-606E-4630-ACEC-7A9140314B7CQ24554340-18E8A568-481E-4122-B3DD-177209FC3200Q24558697-B92EFD08-A430-40D4-8658-239B24026156Q24606095-C8E76706-A023-407D-BF48-9AF4C0F41E0FQ24634681-DE10E42F-2FCF-46C3-8DCF-D00F965518B7Q24645635-7507D2CF-70DE-416D-8FA3-B817F783795FQ24647043-4956208F-8437-4EE8-8902-30B075F841CBQ24651077-DC271633-E048-4EBF-866C-BE171F9D633FQ24669993-8BB33694-06FA-4A81-9DF7-518D240BFCE4Q24670601-709992D0-47C9-4B14-9099-EAB798326235Q24672993-E1A0D61B-A7DB-4B00-8A50-EC6EB43890DBQ24680648-219E369A-F558-4B6F-82B3-AE0141129F7DQ24792862-7C2945D8-8D01-47D3-8574-0DEB27DB8329Q24798323-975FA271-5D40-4B5F-B8D0-92B47D2B0519Q24802478-C3A1C237-C2CB-4787-ADEF-99484C1C554AQ24806310-7BBCEA04-D406-4AD7-A110-B43FFD4C5B1CQ24807291-0D5C7CF8-FD0F-4E67-A238-396BF9BEB37CQ24808657-DFDD253D-C224-4ADF-B718-43E83E1E02DBQ24811688-12ABAAE8-C156-4DA3-A280-EB92C4089C94Q24814060-BE1EA67A-3B2F-4095-B9E4-E0004377FE2AQ24816846-5AC13ECF-C9F5-4C6F-9C46-9DA28F87CA09Q25257643-9B4D57AC-9D45-4C68-B62A-8528C57F184CQ27312399-DE786690-4B1F-439C-A8D5-FB683F21EEA6Q27320687-C5AA6989-DB3E-4206-8EB4-030E73FAD84EQ27321418-D3C96693-1FAB-4743-9E32-7A5A1C757D35Q27345572-E9E99F95-6264-47B5-AE6D-961D5675F402Q27477859-6F9D5323-CBFE-4118-A8EE-F216CF442A3DQ27650133-53D9A572-7E1B-4A54-81E6-5DC12F7DC563Q27728153-BCD24A58-D3C1-48F9-96E9-C2FCA12E6E25Q28272788-1F304C01-97DD-4068-9B9A-E8287959650AQ28343321-769DFD09-D9DE-4692-86DC-9DFD49F506E9Q28360742-22DD96EF-FE99-47AD-84D2-DAA2D6E3A22DQ28362567-0DBC0CFD-2A62-453C-913E-4381CFC34C56Q28364133-44BC1574-E310-43CD-AE4E-61D46F224AD5Q28367673-5DF961DE-5571-4BA3-8A8F-5B8153C99262Q28369127-887AAAE8-A461-4C7D-9FBE-1035093699FCQ28369495-5A7AB2B2-772E-4BE1-B7C8-7CE9B9B2AC11Q28369574-EA453D71-B11E-4802-80C8-1E6876163E66
P2860
Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene
description
1992 nî lūn-bûn
@nan
1992 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Detection of replication-compe ...... grated beta-galactosidase gene
@ast
Detection of replication-compe ...... grated beta-galactosidase gene
@en
type
label
Detection of replication-compe ...... grated beta-galactosidase gene
@ast
Detection of replication-compe ...... grated beta-galactosidase gene
@en
prefLabel
Detection of replication-compe ...... grated beta-galactosidase gene
@ast
Detection of replication-compe ...... grated beta-galactosidase gene
@en
P2860
P3181
P1433
P1476
Detection of replication-compe ...... grated beta-galactosidase gene
@en
P2093
P2860
P304
P3181
P407
P4510
P577
1992-04-01T00:00:00Z